Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NUTROPIN AQ for Hypopituitarism: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 20 adverse event reports in the FDA FAERS database where NUTROPIN AQ was used for Hypopituitarism.

Most Reported Side Effects for NUTROPIN AQ

Side Effect Reports % Deaths Hosp.
Drug dose omission 25 16.2% 0 2
Growth retardation 24 15.6% 0 1
Headache 21 13.6% 1 3
Arthralgia 15 9.7% 0 2
Insulin-like growth factor increased 14 9.1% 0 2
Scoliosis 12 7.8% 0 0
Weight increased 9 5.8% 0 0
Attention deficit/hyperactivity disorder 8 5.2% 0 0
Constipation 7 4.6% 0 2
Fatigue 7 4.6% 0 2
Insulin-like growth factor decreased 7 4.6% 0 0
Asthenia 6 3.9% 0 0
Death 6 3.9% 6 0
Pyrexia 6 3.9% 0 3
Cough 5 3.3% 0 3

Other Indications for NUTROPIN AQ

Growth hormone deficiency (54) Body height below normal (37) Product used for unknown indication (16) Renal failure chronic (12) Turner's syndrome (9)

Other Drugs Used for Hypopituitarism

SOMATROPIN (5,842) LONAPEGSOMATROPIN-TCGD (225) HYDROCORTISONE (208) LEVOTHYROXINE (84) TESTOSTERONE (67) DESMOPRESSIN (53) SOMATROGON-GHLA (38) DUPILUMAB (29) SOMATREM (22) CORTISONE (14)

Related Pages

NUTROPIN AQ Full Profile All Hypopituitarism Drugs NUTROPIN AQ Demographics NUTROPIN AQ Timeline